## XPEV: XPeng Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -10.1% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($16.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. EPMB signs deal to assemble Xpeng's G6 and X9 models in Malaysia**
- Source: Reuters | 20251215T082100 | Bullish | Relevance: 100%
- EP Manufacturing Berhad (EPMB) has signed a deal with Chinese automaker Xpeng to assemble its G6 and X9 electric vehicle models at EPMB's facilities in Malacca, Malaysia. Assembly of the G6 electric SUV is set to begin by March 31 next year, with the X9 minivan following by May 25, 2026. This partnership aims to establish Malaysia as a strategic base for Xpeng's Southeast Asia expansion and optimize EPMB's plant capacity.

**2. XPENG kick-starts local EV production in Malaysia (XPEV:NYSE)**
- Source: Seeking Alpha | 20251215T070918 | Bullish | Relevance: 100%
- XPENG has announced a strategic partnership with EP Manufacturing Berhad for local electric vehicle production in Malacca, Malaysia. This initiative marks XPENG's third such project globally, with mass production scheduled to commence in 2026. The collaboration signifies XPENG's expansion into the Malaysian market for EV manufacturing.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 5 |

**Top Holders:**
- Alibaba Group Holdin: 4.3% (0.0%)
- TMT General Partner : 3.3% (-0.4%)
- Primecap Management : 1.8% (-3.7%)
- UBS Group AG: 1.3% (+23.8%)
- Marshall Wace LLP: 0.7% (+244.3%)

### Key Risks

1. Long-term trend broken: trading 11.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.36 indicates undervaluation relative to growth. Revenue growth strong at 42% YoY. Institutional flow bullish (3 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.9B |
| Beta | 1.05 |
| 52W Range | $11.14 - $28.23 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.36 |
| Forward P/E | 7.0 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -11.6% to -10.1% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 14.1pp (needs >4.0% for momentum thesis). AM_20 at -10.2% indicates price below own 20MA trend. Underperforming sector by 14.2pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. OFD pattern: -FTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -10.09% (CS: 3) | Weak |
| RSI_14 | 36.4 | Neutral |
| MACD Histogram | -0.18 | Bearish |
| vs SMA20 | 0.897x | Below |
| vs SMA50 | 0.831x | Below |
| vs SMA200 | 0.885x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $18.31
- **Stop Loss:** $16.27 (11.1% risk)
- **Target:** $20.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 588
- **Position Value:** $10,766.28
- **Portfolio %:** 10.77%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-03-17 (Est: $0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.16 | +65.8% |
| 2025Q2 | $-1.06 | $-0.41 | +61.4% |
| 2025Q1 | $-1.51 | $-0.45 | +70.2% |
| 2024Q4 | $-1.45 | $-1.47 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*